Purespring Therapeutics

R&D

Purespring on nephrology & gene therapy in kidney disease

Purespring CEO Haseeb Ahmad discusses transforming the treatment of kidney disease, an area of enormous unmet need, and the company's gene therapy.

News

City Therapeutics' $135m debut, and other bio financing news

Our round-up of recent biotech financings features a strong first round for City Therapeutics, a new RNAi venture led by biotech doyen John Maraganore, and additional cash for Purespring, J

R&D

Richard Francis on his Purespring plans: the pharmaphorum po...

In this episode of the pharmaphorum podcast, our news editor Richard Staines talks to Richard Francis, who took over as CEO of gene therapy company Purespring Therapeutics earlier this mont

Purespring on nephrology & gene therapy in kidney disease

City Therapeutics' $135m debut, and other bio financing news

Richard Francis on his Purespring plans: the pharmaphorum po...

Agios shares slide as it abandons sickle cell candidate

Discover a new era of healthcare panel engagement: Grounded ...

Purespring Therapeutics

Editor's Picks